Black Diamond Therapeutics Inc (BDTX) - Financial and Strategic SWOT Analysis Review

November 2021 | 51 pages | ID: B5648CE90567EN
GlobalData

Abstracts

Black Diamond Therapeutics Inc (BDTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Black Diamond Therapeutics Inc (Black Diamond) is a precision oncology medicine company. It discovers small molecules and tumor agnostic therapies for the treatment of cancer. The company’s pipeline product candidates include BDTX-189, which targets cancers including bladder, breast, colon, endometrial, gastric, and non-small cell lung cancer; and BDTX-1535, a brain-penetrant small-molecule inhibitor for the treatment of glioblastoma, affecting the brain or spine. It is also developing its Mutation-Allostery-Pharmacology (MAP) technology platform, to identify oncogenic mutations that promote cancer. Black Diamond is headquartered in Cambridge, Massachusetts, the US.

Black Diamond Therapeutics Inc Key Recent Developments

Nov 08,2021: Black Diamond Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Nov 08,2021: Black Diamond Therapeutics to Present at Upcoming Investor Conferences
Sep 21,2021: Black Diamond Therapeutics to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
Aug 12,2021: Black Diamond Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Aug 10,2021: Black Diamond Therapeutics announces appointment of Mark Velleca, M.D., Ph.D. to board of directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Black Diamond Therapeutics Inc - Key Facts
Black Diamond Therapeutics Inc - Key Employees
Black Diamond Therapeutics Inc - Key Employee Biographies
Black Diamond Therapeutics Inc - Major Products and Services
Black Diamond Therapeutics Inc - History
Black Diamond Therapeutics Inc - Company Statement
Black Diamond Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Black Diamond Therapeutics Inc - Business Description
Black Diamond Therapeutics Inc - Corporate Strategy
Black Diamond Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Black Diamond Therapeutics Inc - Strengths
Black Diamond Therapeutics Inc - Weaknesses
Black Diamond Therapeutics Inc - Opportunities
Black Diamond Therapeutics Inc - Threats
Black Diamond Therapeutics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Black Diamond Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Black Diamond Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Black Diamond Therapeutics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 08, 2021: Black Diamond Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Nov 08, 2021: Black Diamond Therapeutics to Present at Upcoming Investor Conferences
Sep 21, 2021: Black Diamond Therapeutics to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
Aug 12, 2021: Black Diamond Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Aug 10, 2021: Black Diamond Therapeutics announces appointment of Mark Velleca, M.D., Ph.D. to board of directors
May 07, 2021: Black Diamond Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
Mar 25, 2021: Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Mar 10, 2021: Black Diamond Therapeutics to present pre-clinical data on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting
Mar 02, 2021: Black Diamond Therapeutics announces pre-clinical data presentations on new programs targeting BRAF and FGFR at ESMO TAT virtual congress 2021
Feb 23, 2021: Black Diamond Therapeutics to Present at Upcoming Investor Conferences

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Black Diamond Therapeutics Inc, Key Facts
Black Diamond Therapeutics Inc, Key Employees
Black Diamond Therapeutics Inc, Key Employee Biographies
Black Diamond Therapeutics Inc, Major Products and Services
Black Diamond Therapeutics Inc, History
Black Diamond Therapeutics Inc, Other Locations
Black Diamond Therapeutics Inc, Subsidiaries
Black Diamond Therapeutics Inc, Key Competitors
Black Diamond Therapeutics Inc, Ratios based on current share price
Black Diamond Therapeutics Inc, Annual Ratios
Black Diamond Therapeutics Inc, Annual Ratios (Cont...1)
Black Diamond Therapeutics Inc, Interim Ratios
Black Diamond Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Black Diamond Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Black Diamond Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Black Diamond Therapeutics Inc, Performance Chart (2017 - 2020)
Black Diamond Therapeutics Inc, Ratio Charts
Black Diamond Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Black Diamond Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021